ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea
· Delayed Price · Currency is KRW
7,100.00
-10.00 (-0.14%)
At close: Apr 29, 2026
ImmuneOncia Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 528,727 | 965,629 | - | - | - | - | |
| Enterprise Value | 505,359 | 934,053 | - | - | - | - | |
| Last Close Price | 7110.00 | 12518.73 | - | - | - | - | |
| PS Ratio | 4754.36 | 8683.03 | - | - | - | - | |
| PB Ratio | 18.61 | 33.98 | - | - | - | - | |
| P/TBV Ratio | 22.11 | 40.38 | - | - | - | - | |
| EV/Sales Ratio | - | 8399.10 | - | - | - | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -0.82 | -0.82 | -0.58 | -0.86 | 0.51 | 0.71 | |
| Net Debt / EBITDA Ratio | 0.86 | 0.86 | 0.97 | 2.40 | 1.90 | 3.86 | |
| Net Debt / FCF Ratio | 1.01 | 1.01 | 0.76 | 2.95 | 1.74 | 20.22 | |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.00 | 0.18 | 0.00 | |
| Quick Ratio | 5.53 | 5.53 | 3.00 | 7.75 | 7.16 | 4.80 | |
| Current Ratio | 6.22 | 6.22 | 3.06 | 7.90 | 7.53 | 4.84 | |
| Return on Equity (ROE) | -114.39% | -114.39% | -22.97% | - | - | - | |
| Return on Assets (ROA) | -58.99% | -58.99% | -26.25% | -21.22% | -21.71% | -18.57% | |
| Return on Capital Employed (ROCE) | -96.90% | -96.90% | -63.90% | -38.80% | -47.30% | -28.10% | |
| Earnings Yield | -5.18% | -2.83% | - | - | - | - | |
| FCF Yield | -4.37% | -2.39% | - | - | - | - | |
| Buyback Yield / Dilution | -24.61% | -24.61% | -7.35% | -0.64% | -12.17% | -904.47% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.